Wikipedia -WSS

Wikipedia

author：leisure time 2025-09-30 00:09:47 - browse：65834

Exterior photo of UnitedHealth Group building — UnitedHealth Group is attempting to buy Amedisys for $3.3 billion. Courtesy UnitedHealth Group

There’s now a two-party showdown for one of the largest home health companies in the country.

UnitedHealth Group and its Optum division on Monday formally proposed to buy Amedisys for $100 per share, or about $3.3 billion.

The offer comes a few weeks after Option Care Health proposed a $3.6 billion takeover. However, Option Care’s deal is an all-stock transaction, whereas UnitedHealth would pay all cash — a potentially more attractive offer for Amedisys shareholders who want a more immediate payout that isn’t tied to the unpredictability of another company’s stock price. Option Care’s offer is technically worth closer to $2.8 billion now, due to the drop in Option Care’s stock price since the merger was announced. Amedisys is recommending shareholders vote in favor of the deal with Option Care.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Medical leaders decry Supreme Court decision on affirmative action
Next article： Morphosys mixed study results for blood cancer drug

WSS

ACIP vaccine advisory panel sees its vacancies filled

Too many hospitalized Covid

PBM reforms clear House panel

Hospitals look to new technology to keep health care workers safe

David Sabatini, ex

Abbott's new heart device gets FDA advisory panel nod

hotspot

Wikipedia

hotspot

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

FDA's Woodcock to retire early next year

How to save PrEP access — and even expand it

Why Eli Lilly’s earnings didn’t quite live up to the hype

New air purifier tech could be key to improving indoor air quality

Childhood cancer progress stalls for Black, Hispanic kids: Report

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Congress must reauthorize a committee to support older Americans

Novavax promises a turnaround & Lilly roils the obesity market

Bernie Sanders gets little from pharma CEOs on drug prices

leisure time

In key trial, Verve's treatment lowers cholesterol levels in patients

Here’s what’s in the FDA plan to include pregnant women in clinical trials

Astellas still sees hope in its gene therapy after four deaths

Long Covid research funding gets a major boost from NIH

ACIP vaccine advisory panel sees its vacancies filled

In key trial, Verve's treatment lowers cholesterol levels in patients

focus

explore

explore

knowledge